Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Effect and mechanism of long non-coding RNA ZEB2-AS1 in the occurrence and development of colon cancer

1 Department of Anorectal Surgery, Dalian Municipal Central Hospital, Dalian, Liaoning 116033, China
2 Department of General Surgery, Shaoxing People's Hospital (Shaoxing Hospital, Zhejiang University School of Medicine)
3 Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310000, China
4 Department of Orthopedics, The Sixth People's Hospital of Cixi, Ningbo 315300, China

Special Issues: Advanced Big Data Analysis for Precision Medicine

Objective: Clarify the expression changes, biological functions and related mechanisms of long non-coding RNA (lncRNA) ZEB2-AS1 in colon cancer tissues. Methods: The expression levels of ZEB2-AS1 in colon cancer tissues and adjacent tissues were detected by qRT-PCR and in situ hybridization methods. Cell biology experiments were performed to detect the proliferation, migration and apoptosis of colon cancer cells when the level of ZEB2-AS1 was overexpression or silencing. Then, Western blot was performed to analyze the effect of ZEB2-AS1 on the expression levels of β-catenin protein and related genes in the signal pathway. Results: We found that the expression level of ZEB2-AS1 in colon cancer tissues was significantly up-regulated compared with that in adjacent normal tissues. In colon cancer cell line of HCT8, overexpression of ZEB2-AS1 could promote cell proliferation and migration, while silencing ZEB2-AS1 would enhance cell apoptosis and inhibit proliferation. Study on the mechanism of ZEB2-AS1 showed that it could promote the expression of β-catenin, activate downstream genes to be transcribed and promote the occurrence and development of tumors. Conclusion: ZEB2-AS1 could promote colon cancer cell proliferation and inhibit apoptosis to promote the progression of colon cancer by upregulating the expression of β-catenin protein. ZEB2-AS1 may be a useful new target for treating colon cancer patients.
  Figure/Table
  Supplementary
  Article Metrics

Keywords long non-coding RNA; ZEB2-AS1; colon cancer; β-catenin protein

Citation: Xu Guo, Yuanming Jing, Haizhou Lou, Qiaonv Lou. Effect and mechanism of long non-coding RNA ZEB2-AS1 in the occurrence and development of colon cancer. Mathematical Biosciences and Engineering, 2019, 16(6): 8109-8120. doi: 10.3934/mbe.2019408

References

  • 1. Y. Yin, J. Zhong, S. W. Li, et al., TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer, Oncotarget,7 (2016), 86755-86765.
  • 2. K. Liu, H. Yao, S. Lei, et al., The miR-124-p63 feedback loop modulates colorectal cancer growth, Oncotarget,8 (2017), 29101-29115.
  • 3. M. Yue, J. L. Charles Richard and Y. Ogawa, Dynamic interplay and function of multiple noncoding genes governing X chromosome inactivation, Biochim. Biophys. Acta,1859 (2016), 112-120.
  • 4. A. A. Butler, W. M. Webb and F. D. Lubin, Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction, Epigenomics,8 (2016), 135-151.
  • 5. C. Kanduri, Long noncoding RNAs: Lessons from genomic imprinting, Biochim. Biophys. Acta,1859 (2016), 102-111.
  • 6. C. Tordonato, P. P. Di Fiore and F. Nicassio, The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors, Front Genet.,6 (2015), 72.
  • 7. J. R. Prensner, M. K. Iyer, O. A. Balbin, et al., Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression, Nat. Biotechnol.,29 (2011), 742-749.
  • 8. W. Li, J. Zheng, J. Deng, et al., Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells, Gastroenterology,146 (2014), 1714-1726.e1715.
  • 9. R. Chen, G. Wang, Y. Zheng, et al., Long non-coding RNAs in osteosarcoma, Oncotarget,8 (2017), 20462-20475.
  • 10. Z. Yang, X. Li, Y. Yang, et al., Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma, Cell Death Dis.,7 (2016), e2389.
  • 11. K. P. Zhu, X. L. Ma and C. L. Zhang, LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis, Mol. Ther.,25 (2017), 2383-2393.
  • 12. B. Wang, Y. Su, Q. Yang, et al., Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma, Mol. Cells,38 (2015), 432-440.
  • 13. Y. Guo, Y. Hu, M. Hu, et al., Long non-coding RNA ZEB2-AS1 promotes proliferation and inhibits apoptosis in human lung cancer cells, Oncol. Lett.,15 (2018), 5220-5226.
  • 14. H. Gao, N. Gong, Z. Ma, et al., LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis, Int. J. Biol. Macromol.,116 (2018), 545-551.
  • 15. P. Diao, H. Ge, Y. Song, et al., Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma, J. Cell. Mol. Med.,23 (2019), 4269-4280.
  • 16. X. Shi, J. Li, L. Ma, et al., Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia, Oncol. Lett.,17 (2019), 4935-4947.
  • 17. C. Xu, H. Cui, H. Li, et al., Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients, J. Buon.,24 (2019), 663-671.
  • 18. S. Xu, D. Kong, Q. Chen, et al., Oncogenic long noncoding RNA landscape in breast cancer, Mol. Cancer,16 (2017), 129.
  • 19. G. Zhang, H. Li, R. Sun, et al., Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2, J. Cell. Mol. Med.,23 (2019), 3271-3279.
  • 20. F. Wang, W. Zhu, R. Yang, et al., LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/beta-catenin pathway, Mol. Cell. Biochem.,456 (2019), 73-83.
  • 21. C. He, W. Yang, J. Yang, et al., Long noncoding RNA MEG3 negatively regulates proliferation and angiogenesis in vascular endothelial cells, DNA Cell Biol.,36 (2017), 475-481.
  • 22. L. E. Dow, K. P. O'Rourke, J. Simon, et al., APC restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer, Cell,161 (2015), 1539-1552.
  • 23. J. N. Anastas and R. T. Moon, WNT signalling pathways as therapeutic targets in cancer, Nat. Rev. Cancer,13 (2013), 11-26.
  • 24. J. Li, B. Yu, P. Deng, et al., KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/beta-catenin signalling, Nat. Commun.,8 (2017), 15146.
  • 25. P. Zhu, Y. Wang, G. Huang, et al., lnc-beta-Catm elicits EZH2-dependent beta-catenin stabilization and sustains liver CSC self-renewal, Nat. Struct. Mol. Biol.,23 (2016), 631-639.

 

Reader Comments

your name: *   your email: *  

© 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved